Viewing Study NCT00829816


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2026-04-22 @ 2:38 PM
Study NCT ID: NCT00829816
Status: COMPLETED
Last Update Posted: 2015-11-10
First Post: 2009-01-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
Sponsor: Medivation, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DIM17
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators